Literature DB >> 26010422

Estimation of treatment effect in a subpopulation: An empirical Bayes approach.

Changyu Shen1, Xiaochun Li1, Jaesik Jeong2.   

Abstract

It is well recognized that the benefit of a medical intervention may not be distributed evenly in the target population due to patient heterogeneity, and conclusions based on conventional randomized clinical trials may not apply to every person. Given the increasing cost of randomized trials and difficulties in recruiting patients, there is a strong need to develop analytical approaches to estimate treatment effect in subpopulations. In particular, due to limited sample size for subpopulations and the need for multiple comparisons, standard analysis tends to yield wide confidence intervals of the treatment effect that are often noninformative. We propose an empirical Bayes approach to combine both information embedded in a target subpopulation and information from other subjects to construct confidence intervals of the treatment effect. The method is appealing in its simplicity and tangibility in characterizing the uncertainty about the true treatment effect. Simulation studies and a real data analysis are presented.

Entities:  

Keywords:  Causal inference; empirical bayes; heterogeneity in treatment effect; subgroup analysis

Mesh:

Year:  2015        PMID: 26010422      PMCID: PMC4814367          DOI: 10.1080/10543406.2015.1052480

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  16 in total

1.  Analysis of randomized comparative clinical trial data for personalized treatment selections.

Authors:  Tianxi Cai; Lu Tian; Peggy H Wong; L J Wei
Journal:  Biostatistics       Date:  2010-09-28       Impact factor: 5.899

2.  Bayesian subset analysis.

Authors:  D O Dixon; R Simon
Journal:  Biometrics       Date:  1991-09       Impact factor: 2.571

Review 3.  A Bayesian approach to subgroup identification.

Authors:  James O Berger; Xiaojing Wang; Lei Shen
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

4.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

5.  Heterogeneity is not always noise: lessons from improvement.

Authors:  Frank Davidoff
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

6.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

7.  Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-10-19       Impact factor: 79.321

8.  EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

Authors:  Lihui Zhao; Lu Tian; Tianxi Cai; Brian Claggett; L J Wei
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

9.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

10.  The Future of Indirect Evidence.

Authors:  Bradley Efron
Journal:  Stat Sci       Date:  2010-05       Impact factor: 2.901

View more
  1 in total

1.  Time course and heterogeneity of treatment effect of the collaborative chronic care model on psychiatric hospitalization rates: A survival analysis using routinely collected electronic medical records.

Authors:  Michael A Ruderman; Bo Kim; Kelly Stolzmann; Samantha Connolly; Christopher J Miller; Mark S Bauer
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.